Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
14/03 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
14/03 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 36Cr | |
+37.96% | 73TCr | |
-7.92% | 35TCr | |
+15.54% | 33TCr | |
-0.15% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+4.21% | 16TCr | |
-1.82% | 16TCr |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals SA Reports Consolidated Earnings Results for the Half Year Ended June 30, 2021